Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Venova Medical

Request full access

Develops vascular access systems for patients requiring renal replacement therapy

Los Gatos, United StatesFounded 2018Health Tech & Medtech

About Venova Medical

Venova Medical, Inc. is a privately held, clinical-stage medical device company founded in 2018 by CEO Erik van der Burg and CMO Dr. Shant Vartanian. The company is focused on addressing the challenges associated with providing optimal and timely vascular access for patients with chronic kidney and end-stage renal diseases who require hemodialysis. Emerging from a residence in Los Gatos, California during the COVID-19 pandemic, the firm has grown to over 10 employees. The business model centers on the development and eventual sale of its proprietary medical device, pending regulatory approvals.

The company's core product is the Velocity™ pAVF System, a technology designed for the percutaneous (through the skin) creation of arteriovenous fistulas (pAVF). A fistula for dialysis is a connection created between an artery and a vein, which is necessary to ensure high blood flow for effective hemodialysis treatment. Traditionally, this requires open surgery. The Velocity™ system offers a minimally invasive alternative, using a needle stick to create the fistula, a procedure that can be performed in an outpatient setting, surgery center, or office. This approach aims to reduce the barriers preventing patients from starting dialysis with the safer AVF procedure, as many currently begin treatment with higher-risk central venous catheters. The system is engineered to provide durable fistula flow, reduce the need for subsequent interventions to help the fistula mature, and ultimately lower healthcare costs.

Venova Medical is actively pursuing regulatory clearance to bring its product to market. The company is conducting clinical trials, including the VENOS-1 and the now fully enrolled VENOS-2 early feasibility study, under an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA). A significant milestone was achieved in September 2024 with the closing of a $30 million Series B financing round. This funding, co-led by Catalyst Health Ventures and a major medical device company, is allocated to further technology development and support the clinical studies required for FDA approval. The company plans to submit an IDE application for a pivotal U.S. trial in the second quarter of 2025.

Source: Dealroom company data

At a glance

Status
Operational
Employees
25
Open positions
1
Dealroom signal
88.2/100
Industry
Health
Sub-industry
Medical Devices
Sector
Cardiology and cardiovascular, Kidney, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2024 $30M $120M ShangBay Capital · Cadence Healthcare Ventures · Aphelion Capital · Mirae Asset Capital ↗
EARLY VC✓Equity / VC Oct 2022 $6.9M $28M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Venova Medical website traffic

Latest recorded traffic for Venova Medical is 1.8K monthly website visits, up 83.7% over the last three months. Venova Medical's team grew 8.7% over the past year.

Latest monthly visits1.8K 3-month web change+83.7% 1-year team growth+8.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Venova Medical in the Los Gatos ecosystem

Live from Dealroom

The Venova Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Catalyst Health Ventures
  • ShangBay Capital
  • Cadence Healthcare Ventures
  • Aphelion Capital
  • Mirae Asset Capital
  • KOFA Healthcare Investments

Other known investors1 additional known investor

  • University of California, San Francisco
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Venova Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Venova Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.